People: PharmAthene Inc (PIP)
10 Dec 2013
Mr. John M. Gill is Independent Director of Pharmathene Inc., since August 3, 2007. From February 2004 to August 3, 2007 served as a member of the Board of Directors and as Chairman of the Audit Committee of Company's predecessor, privately-held PharmAthene (“Former PharmAthene”). Mr. Gill is currently the President, Chief Executive Officer and a Director of TetraLogic Pharmaceuticals Corporation, a private biopharmaceutical company, and has served in these positions since 2003. He is also an advisor or director of other private companies, the Kimmel Cancer Center at Thomas Jefferson University, and other non-profit community organizations. Mr. Gill has previously held positions at 3-Dimensional Pharmaceuticals and SmithKline Beecham. Mr. Gill received a Bachelor of Arts degree from Rutgers University.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|